Skip to content. | Skip to navigation

Personal tools
Log in
You are here: Home Research Genetic enhancement Biotechnology at CIP

Biotechnology at CIP

CIP’s Guiding principles for development and deployment of genetically engineered organisms

CIP believes that genetic engineering has an important role to play in improving production and utilization of food crops in developing countries. Genetically engineered organisms can thus contribute to CIP’s principal goals of eliminating poverty and increasecsing food security.

CIP’s decisions about, and investments in, genetic engineering will be guided by the following principles:

Keeping safety considerations in mind, CIP will use genetic engineering when it believes that other techniques have not been effective in achieving the desired ends.

CIP will take care to develop genetically engineered products appropriate for use by resource-poor farmers, that is, products with needed traits and minimum proprietary restrictions and technology-associated costs, which can be easily transferred to and managed by resource-poor farmers.

CIP will not seek to recover royalties or other types of revenues when transferring genetically engineered products to resource-poor farmers or their representatives. For developing genetically engineered organisms CIP will give priority to using genes that occur naturally in closely related species unless they prove to be significantly less effective than genes in non-related species.

CIP will conduct its work on genetically engineered organisms in a participatory and transparent manner, considering the diversity of opinions and values of its partners, civil society organizations and other stakeholders.

CIP will evaluate, on a case-by-case basis, and following science-based criteria, potential risks associated with application and deployment of genetically engineered organisms, including aspects such as crop characteristics, environment, non-target organisms, food safety, and cultural, social and economic conditions.

CIP will work with national partners, using the best expertise available, to address potential risks and assure confidence in the product. If a recipient country lacks the expertise to conduct its own risk assessment, CIP will work with national partners to develop appropriate strategies and methodologies.

CIP is sensitive to concerns surrounding the release of genetically engineered products in the centre of origin and diversity and will always exercise extreme caution in these cases.

CIP will comply with national or regional biosafety, food, environmental and policy regulations for deployment of genetically engineered organisms. CIP will not distribute genetically engineered organisms to any country lacking biosafety regulations.

Document Actions

Menu CIP >